Vilanterol Trifenatate

CHEMBL1084172 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

774.8 g/mol

LogP

—

Phase

4

Vilanterol trifenatate is the triphenylacetate salt of vilanterol, an ultra-long-acting beta-2 agonist (LABA) used for maintenance therapy of asthma and COPD in combination with other agents. The trifenatate salt form is used in the inhaled powder formulations marketed for once-daily maintenance bronchodilation. Like the free base, it provides >24 hours of beta-2 receptor-mediated bronchial smooth muscle relaxation.

Molekularmasse

774,8000 g/mol

TPSA

128,00 Å²

Therapeutische Bereiche

Asthma Chronic Obstructive Pulmonary Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

O=C(O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O

InChI

InChI=1S/C24H33Cl2NO5.C20H16O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;21-19(22)20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-15H,(H,21,22)/t24-;/m0./s1

Molecular Formula

C44H49Cl2NO7

HBD / HBA

5 / 8

Rotierbare Bindungen

20

Schwere Atome

54

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Vilanterol trifenatate is the triphenylacetate salt of vilanterol, an ultra-long-acting beta-2 agonist (LABA) used for maintenance therapy of asthma and COPD in combination with other agents. The trifenatate salt form is used in the inhaled powder formulations marketed for once-daily maintenance bronchodilation. Like the free base, it provides >24 hours of beta-2 receptor-mediated bronchial smooth muscle relaxation.

Yes, Vilanterol Trifenatate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1084172. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 44482554. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Vilanterol Trifenatate auf PillFYI

Struktur

Schnelldaten

Formel: C44H49Cl2NO7
Synonyme: 4

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.